Supplemental material
Open access
18,593
Views
51
CrossRef citations to date
0
Altmetric
Research Article
Phase I clinical trial of safety of L-serine for ALS patients
Todd D. LevinePhoenix Neurological Associates, Phoenix, Arizona,
, Robert G. MillerForbes Norris MDA/ALS Research and Treatment Center, California Pacific Medical Center, San Francisco, California,
, Walter G. BradleyDepartment of Neurology, Miller School of Medicine, University of Miami, Miami, Florida, and Correspondence[email protected]
, Dan H. MooreForbes Norris MDA/ALS Research and Treatment Center, California Pacific Medical Center, San Francisco, California,
, David S. SapersteinPhoenix Neurological Associates, Phoenix, Arizona,
, Lynne E. FlynnPhoenix Neurological Associates, Phoenix, Arizona,
, Jonathan S. KatzForbes Norris MDA/ALS Research and Treatment Center, California Pacific Medical Center, San Francisco, California,
, Dallas A. ForshewForbes Norris MDA/ALS Research and Treatment Center, California Pacific Medical Center, San Francisco, California,
, James S. MetcalfBrain Chemistry Labs, Institute for Ethnomedicine, Jackson, Wyoming, USA
, Sandra A. BanackBrain Chemistry Labs, Institute for Ethnomedicine, Jackson, Wyoming, USA
& Paul A. CoxBrain Chemistry Labs, Institute for Ethnomedicine, Jackson, Wyoming, USA
show all
Pages 107-111
|
Received 23 May 2016, Accepted 03 Aug 2016, Published online: 02 Sep 2016
Related Research Data
Oral l -serine supplementation reduces production of neurotoxic deoxysphingolipids in mice and humans with hereditary sensory autonomic neuropathy type 1
Source:
American Society for Clinical Investigation
Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease.
Source:
Elsevier BV
Mechanisms of l-Serine Neuroprotection in vitro Include ER Proteostasis Regulation
Source:
Springer Science and Business Media LLC
Phase I clinical trial of safety of L-serine for ALS patients
Source:
Figshare
Is exposure to cyanobacteria an environmental risk factor for amyotrophic lateral sclerosis and other neurodegenerative diseases
Source:
Informa UK Limited
The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function
Source:
Elsevier BV
Mutations in the SPTLC1 gene are a cause of amyotrophic lateral sclerosis that may be amenable to serine supplementation [preprint]
Source:
Cold Spring Harbor Laboratory
The ALSFRSr predicts survival time in an ALS clinic population.
Source:
Ovid Technologies (Wolters Kluwer Health)
l-Serine synthesis in the central nervous system: A review on serine deficiency disorders
Source:
Elsevier BV
The Role of Environmental Exposures in Neurodegeneration and Neurodegenerative Diseases
Source:
Oxford University Press (OUP)
Long-Term l-Serine Administration Reduces Food Intake and Improves Oxidative Stress and Sirt1/NFκB Signaling in the Hypothalamus of Aging Mice.
Source:
Frontiers Media SA
Use of respiratory function tests to predict survival in amyotrophic lateral sclerosis
Source:
Informa UK Limited
Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS
Source:
Elsevier BV
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.